Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone in Acute Schizophrenia (PEARL 1)
NCT00549718Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Oct 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of lurasidone in schizophrenia, sponsored by Sumitomo Pharma America. Started Oct 2007; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00549718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549718.